TI
IRWD icon

Trexquant Investment’s Ironwood Pharmaceuticals IRWD Stock Holding History

Trexquant Investment’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-831,416
Closed -$5.42M – 1691
2024
Q2 		$5.42M Buy
831,416
+701,941
+542% +$4.97M 0.08% 379
2024
Q1 		$1.13M Buy
+129,475
New +$1.57M 0.02% 873
2023
Q3 		– Sell
-117,956
Closed -$1.26M – 1633
2023
Q2 		$1.26M Sell
117,956
-105,715
-47% -$1.14M 0.03% 686
2023
Q1 		$2.35M Buy
223,671
+46,985
+27% +$526K 0.06% 398
2022
Q4 		$2.19M Buy
176,686
+62,967
+55% +$714K 0.06% 382
2022
Q3 		$1.18M Buy
113,719
+65,959
+138% +$748K 0.04% 485
2022
Q2 		$551K Sell
47,760
-16,655
-26% -$196K 0.02% 775
2022
Q1 		$810K Buy
+64,415
New +$738K 0.04% 563
2021
Q2 		– Sell
-52,735
Closed -$590K – 1290
2021
Q1 		$590K Buy
+52,735
New +$557K 0.05% 450
2020
Q4 		– Sell
-36,948
Closed -$332K – 1247
2020
Q3 		$332K Sell
36,948
-30,421
-45% -$302K 0.02% 879
2020
Q2 		$695K Buy
67,369
+24,856
+58% +$254K 0.05% 542
2020
Q1 		$429K Sell
42,513
-12,127
-22% -$143K 0.03% 714
2019
Q4 		$727K Buy
+54,640
New +$602K 0.04% 448
2019
Q3 		– Sell
-23,977
Closed -$262K – 980
2019
Q2 		$262K Buy
+23,977
New +$269K 0.02% 631
2019
Q1 		– Sell
-37,063
Closed -$322K – 1133
2018
Q4 		$322K Buy
37,063
+24,515
+195% +$281K 0.02% 759
2018
Q3 		$194K Sell
12,548
-42,747
-77% -$676K 0.01% 832
2018
Q2 		$885K Sell
55,295
-18,206
-25% -$269K 0.06% 401
2018
Q1 		$950K Buy
+73,501
New +$916K 0.07% 423
2017
Q2 		– Sell
-29,731
Closed -$425K – 961
2017
Q1 		$425K Buy
+29,731
New +$406K 0.05% 608
2016
Q3 		– Sell
-58,984
Closed -$646K – 851
2016
Q2 		$646K Buy
+58,984
New +$576K 0.08% 384
2016
Q1 		– Sell
-38,646
Closed -$375K – 1037
2015
Q4 		$375K Buy
+38,646
New +$374K 0.03% 777

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's IRWD Position: Q3 2024 in Review

Trexquant Investment sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 831,416 shares — an estimated $5.42M sold.

Trexquant Investment first reported a position in IRWD in Q4 2015 and held it in 21 quarters. The position peaked at $5.42M in Q2 2024. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Trexquant Investment reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 831,416 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $5.42M.
  • Trexquant Investment first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 21 quarters.
  • Trexquant Investment's Ironwood Pharmaceuticals position peaked at $5.42M in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.